OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysbiosis signature of mycobiota in colon polyp and colorectal cancer
Renyuan Gao, Cheng Kong, Hui‐Jing Li, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2017) Vol. 36, Iss. 12, pp. 2457-2468
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong, Jun Yu
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 690-704
Closed Access | Times Cited: 995

The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases
Mathias L. Richard, Harry Sokol
Nature Reviews Gastroenterology & Hepatology (2019)
Closed Access | Times Cited: 350

Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 298

The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Lidia Sánchez‐Alcoholado, Bruno Ramos‐Molina, A. Otero, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1406-1406
Open Access | Times Cited: 279

Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Solomon Habtemariam
Pharmacological Research (2020) Vol. 155, pp. 104722-104722
Closed Access | Times Cited: 242

The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly
Fen Zhang, Dominik Aschenbrenner, Ji Youn Yoo, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e969-e983
Closed Access | Times Cited: 225

Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis
Faraz Bishehsari, Phillip A. Engen, Nailliw Z. Preite, et al.
Genes (2018) Vol. 9, Iss. 2, pp. 102-102
Open Access | Times Cited: 185

Identification of microbial markers across populations in early detection of colorectal cancer
Yuanqi Wu, Na Jiao, Ruixin Zhu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 171

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 112

The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Chengxiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 85

Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
Karolina Kaźmierczak-Siedlecka, Karolina Skonieczna‐Żydecka, Ted R. Hupp, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 81

Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Hourieh Sadrekarimi, Zhanna R. Gardanova, Morteza Bakhshesh, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 81

Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 866-866
Open Access | Times Cited: 72

A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases
Qiulong Yan, Shenghui Li, Qingsong Yan, et al.
Cell (2024) Vol. 187, Iss. 12, pp. 2969-2989.e24
Closed Access | Times Cited: 36

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases
Ekaterina Avershina, A. Qureshi, Hanne C. Winther‐Larsen, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2

Mycobiome in the Gut: A Multiperspective Review
Voon Kin Chin, Phelim Voon Chen Yong, Pei Pei Chong, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 116

Characterizing the Human Mycobiota: A Comparison of Small Subunit rRNA, ITS1, ITS2, and Large Subunit rRNA Genomic Targets
Michael Hoggard, Anna Vesty, Giselle C. Wong, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 105

Malassezia spp. Yeasts of Emerging Concern in Fungemia
Wafa Rhimi, Bart Theelen, Teun Boekhout, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 84

Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Rajagopalaboopathi Jayasudha, Taraprasad Das, Sama Kalyana Chakravarthy, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243077-e0243077
Open Access | Times Cited: 78

The role of gut mycobiome in health and diseases
Lin Zhang, Hui Zhan, Wenye Xu, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 75

Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis
Karolina Kaźmierczak-Siedlecka, Aleš Dvořák, Marcin Folwarski, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1326-1326
Open Access | Times Cited: 73

Mycobiome and Cancer: What Is the Evidence?
Natalia G. Vallianou, Dimitris Kounatidis, Gerasimos Socrates Christodoulatos, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3149-3149
Open Access | Times Cited: 65

Microbiota-driven mechanisms at different stages of cancer development
Elena Ivleva, Sergei I. Grivennikov
Neoplasia (2022) Vol. 32, pp. 100829-100829
Open Access | Times Cited: 44

Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
Luying He, Zhangfeng Zhong, Man Chen, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top